Leukapheresis
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Overview
Leukapheresis is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Leukapheresis clinical trials
Explore related
Medical disclaimer. This page summarizes research about Leukapheresis for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.